Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD1 | Q15139 | 11/20 | 0.72 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.55 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.55 |
| ▸ | CTSL | P07711 | 6/20 | 0.40 |
| ▸ | CTSB | P07858 | 5/20 | 0.40 |
| ▸ | CTSS | P25774 | 5/20 | 0.40 |
| ▸ | CTSK | P43235 | 4/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL935843 | 0.84 | PRKD1 (1.00) | PRKD1PRKD3PRKD2CTSLCTSB | |
| SCHEMBL935844 | 0.84 | PRKD1 (1.00) | PRKD1PRKD3PRKD2CTSLCTSB | |
| SCHEMBL6923923 | 0.83 | PRKD1 (0.82) | PRKD1PRKD3PRKD2 | |
| SCHEMBL937974 | 0.81 | PRKD1 (0.72) | PRKD1PRKD3PRKD2CTSLCTSB | |
| SCHEMBL6922606 | 0.81 | PRKD1 (0.78) | PRKD1PRKD3PRKD2CTSK | |
| SCHEMBL936281 | 0.79 | PRKD1 (0.73) | PRKD1PRKD3PRKD2CTSK | |
| SCHEMBL6923731 | 0.77 | PRKD1 (0.70) | PRKD1PRKD3PRKD2CTSK | |
| SCHEMBL936642 | 0.76 | PRKD1 (0.85) | PRKD1PRKD3PRKD2CTSLCTSB | |
| SCHEMBL936644 | 0.76 | PRKD1 (0.85) | PRKD1PRKD3PRKD2CTSLCTSB | |
| SCHEMBL936497 | 0.75 | PRKD1 (0.82) | PRKD1PRKD3PRKD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011009484-A1 | ARYLPYRAZOLES AND ARYLISOXAZOLES AND THEIR USE AS PKD MODULATORS | NOVARTIS AG (CH) | 2011-01-27 | — | — | WO | disclosed |